marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Teladoc Health Balance Sheet 2011-2024 | TDOC
Annual Balance Sheet Teladoc Health
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
426 M | 631 M | 345 M | 658 M | -71.2 M | 45.2 M | 244 M | -5.59 M | -28.6 M | -20.4 M | -212 K | - | - |
Long Term Debt |
1.54 B | 1.54 B | 1.23 B | 1.38 B | 440 M | 415 M | 207 M | 42.4 M | 25.2 M | 25.2 M | 3 M | - | - |
Long Term Debt Current |
10.8 M | 13.6 M | 12.7 M | 11.4 M | 5.09 M | - | - | 2 M | 1.25 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 499 M | 453 M | 225 M | 51.7 M | 33.2 M | 25.8 M | 3.19 M | - | - |
Total Current Liabilities |
421 M | 400 M | 331 M | 333 M | 90.2 M | 62.4 M | 40.3 M | 21.1 M | 18 M | - | - | - | - |
Total Liabilities |
- | - | - | - | 589 M | 516 M | 265 M | 72.8 M | 51.2 M | 38.8 M | 8.33 M | - | - |
Deferred Revenue |
95.7 M | 102 M | 75.6 M | 65.8 M | 12.5 M | 7.65 M | 4.11 M | 1 M | 831 K | - | - | - | - |
Retained Earnings |
-15.2 B | -15 B | -1.42 B | -993 M | -508 M | -409 M | -312 M | -205 M | -131 M | -72.5 M | -55.5 M | - | - |
Total Assets |
4.39 B | 4.35 B | 17.7 B | 17.8 B | 1.6 B | 1.53 B | 824 M | 304 M | 230 M | 92 M | 27.4 M | - | - |
Cash and Cash Equivalents |
1.12 B | 918 M | 893 M | 733 M | 514 M | 424 M | 42.8 M | 50 M | 55.1 M | 46.4 M | 3.21 M | - | - |
Book Value |
4.39 B | 4.35 B | 17.7 B | 17.8 B | 1.01 B | 1.01 B | 559 M | 231 M | 179 M | 53.2 M | 19.1 M | - | - |
Total Shareholders Equity |
2.33 B | 2.31 B | 16 B | 15.9 B | 1.01 B | 1.01 B | 559 M | 231 M | 179 M | -67.5 M | -55.5 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Teladoc Health
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
991 M | 990 M | 1.54 B | 1.54 B | 1.54 B | 1.54 B | 1.54 B | 1.54 B | 1.53 B | - | 1.53 B | 1.23 B | 1.21 B | 1.2 B | 1.35 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 440 M | 440 M | 440 M | 440 M | 415 M | 415 M | 415 M | 415 M | 207 M | 207 M | 207 M | 42.4 M | 42.4 M | 42.5 M | 27.1 M | 42.4 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 25 M | 25.2 M | 25.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.02 B | 2.02 B | - | 2.07 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
88.3 M | 95.4 M | 101 M | 95.7 M | 99.2 M | 107 M | 95.9 M | 102 M | 90.2 M | - | 83.8 M | 75.6 M | 72.9 M | 69.3 M | 70.5 M | 52.4 M | 52.4 M | 52.4 M | 52.4 M | 12.5 M | 12.5 M | 12.3 M | 12.5 M | 7.65 M | 7.65 M | 7.65 M | 7.65 M | 4.11 M | 3.52 M | 2.41 M | 1.62 M | 1 M | 1 M | 1 M | 1 M | 831 K | 831 K | 831 K | 831 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-16.2 B | -16.1 B | -15.3 B | -15.2 B | -15.2 B | -15.1 B | -15.1 B | -15 B | -11.2 B | - | -8.02 B | -1.42 B | -1.41 B | -1.33 B | -1.19 B | -993 M | -993 M | -993 M | -993 M | -508 M | -508 M | -508 M | -508 M | -409 M | -409 M | -409 M | -409 M | -312 M | -312 M | -312 M | -312 M | -205 M | -205 M | -205 M | -205 M | -131 M | -131 M | -131 M | -131 M | -72.5 M | -72.5 M | -72.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
3.53 B | 3.52 B | 4.32 B | 4.39 B | 4.33 B | 4.32 B | 4.31 B | 4.35 B | 8.1 B | - | 11.1 B | 17.7 B | 17.7 B | 17.6 B | 17.6 B | 17.8 B | 17.8 B | 17.8 B | 17.8 B | 1.6 B | 1.6 B | 1.6 B | 1.6 B | 1.53 B | 1.53 B | 1.53 B | 1.53 B | 824 M | 824 M | 824 M | 824 M | 304 M | 304 M | 304 M | 304 M | 230 M | 230 M | 230 M | 230 M | 91.8 M | 92 M | 92 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
1.24 B | 1.16 B | 1.1 B | 1.12 B | 1.03 B | 959 M | 889 M | 918 M | 900 M | 881 M | 836 M | 893 M | 824 M | 784 M | 720 M | 733 M | 733 M | 733 M | 733 M | 514 M | 514 M | 514 M | 514 M | 424 M | 424 M | 424 M | 424 M | 42.8 M | 42.8 M | 42.8 M | 42.8 M | 50 M | 50 M | 50 M | 50 M | 55.1 M | 55.1 M | 55.1 M | 55.1 M | 46.4 M | 46.4 M | 46.4 M | - | 3.21 M | - | - | - | 8.69 M | - | - | - | - | - | - | - |
Book Value |
1.51 B | 1.5 B | 4.32 B | 2.33 B | 4.33 B | 4.32 B | 4.31 B | 4.35 B | 8.1 B | - | 11.1 B | 17.7 B | 17.7 B | 17.6 B | 17.6 B | 17.8 B | 17.8 B | 17.8 B | 17.8 B | 1.6 B | 1.6 B | 1.6 B | 1.6 B | 1.53 B | 1.53 B | 1.53 B | 1.53 B | 824 M | 824 M | 824 M | 824 M | 304 M | 304 M | 304 M | 304 M | 230 M | 230 M | 230 M | 230 M | 91.8 M | 92 M | 92 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
1.51 B | 1.5 B | 2.29 B | 2.33 B | 2.29 B | 2.3 B | 2.29 B | 2.31 B | 6.05 B | 6.08 B | 9.14 B | 16 B | 16 B | 16 B | 15.8 B | 15.9 B | 15.9 B | 15.9 B | 15.9 B | 1.01 B | 1.01 B | 1.01 B | 1.01 B | 1.01 B | 1.01 B | 1.01 B | 1.01 B | 559 M | 559 M | 559 M | 559 M | 231 M | 231 M | 231 M | 231 M | 179 M | 179 M | 179 M | 179 M | -67.5 M | -67.5 M | -67.5 M | - | -55.5 M | - | - | - | -46.5 M | - | - | - | - | - | - | - |
All numbers in USD currency